ABSTRACT
Introduction
Epidemiologic studies have reported that essential hypertension (EH) is prevalent, affecting approx 20%-25% of the adult population in the world, becoming a major worldwide public health issue.1,2 Hypertension can increase the risk of coronary heart disease, stroke and congestive heart failure. EH is considered to be a multifactorial, complex disease. Family and twin studies have shown that about 80% EH is determined by genetic factors interacting with environmental factors.3-6 Human calcitonin gene-related peptide (CGRP), a very potent vasodilating neuropeptide, includes alpha-CGRP (CALCA) and beta-CGRP (CALCB). The growing evidence from animal and human studies indicates that CGRP may play an important role in the initiation, progression and maintenance of hypertension via the alterations in its synthesis and release.
The human CALCA gene is located on chromosome 11p15.2-p15.1 and codes for both calcitonin and alpha-CGRP through alternative RNA splicing of gene transcripts, which spans approximately 3.8 kb, and contains five exons. Single nucleotide polymorphisms (SNPs) are the most common form of human genetic variation, and they may contribute to the individual susceptibility to EH. Many studies have demonstrated that SNPs in genes may not only affect the expression or activities of the enzymes or proteins but are associated with the risk of EH; such as the genes for angiotensinogen,7 endothelial NO synthase8 and CYP3A5. 9 The aims of this study were to discover a polymorphism in the 5' flanking region of the CALCA gene in Chinese subjects and to assess the association between this gene and EH. To test this hypothesis, we performed genotyping analyses for the CALCA T-692C polymorphism in a population-based case-control study of the Chinese Han population.
Methods

Clinical Materials
From December 2005 to August 2006, eligible patients for this population-based case-control study of EH were recruited at our community program of EH prevention and cure in Hunan province. They were genetically unrelated ethnic Han Chinese and were from Hunan province in middle China. There were 293 EH patients (male/female ratio=1.53). EH was diagnosed based on the following criteria: seated systolic blood pressure (BP) ≥140 mmHg or diastolic BP ≥90 mmHg on three occa-sions within 2 months after the first BP reading. Patients diagnosed as having secondary hypertension were excluded. A total of 208 normotensive age-matched healthy individuals (male/female ratio =1.70) served as control subjects. All control subjects had systolic BP <140 mmHg and diastolic BP <90 mmHg. The study was approved by the ethnic committee of Xiangya Hosptial.
Genetic Studies
Based on the information obtained from the NCBI SNP database, we chose a SNP CALCA T-692C that had a minor allele frequency of more than 10%. Blood samples were collected from all participants and genomic DNA was extracted from the peripheral blood leukocyte pellet by the standard method with proteinase K digestion and followed by phenol-chloroform extraction and ethanol precipitation. The CALCA genotypes were detected by the polymerase chain reaction (PCR) restriction fragment length polymorphism assay with primers of 5'CG CATCTGTACCTTGCAACT3' (forward) and 5'TCAA ATT CCCGCTCACTTTA3' (reverse). The 20 μl PCR mixture consisted of approximately 100 ng of genomic DNA, 40 pmol of each primer, 40 pmol dNTP, 2 μl 10×PCR buffer, and 2 U Taq DNA polymerase (Sangon, China). The PCR profile consisted of an initial melting step of 94 ℃ for 5 minutes, 38 cycles of 94°C for 50 seconds, 57 ℃ for 50 seconds and 72°C for 1 minute, and a final extension step of 72°C for 10 minutes. The 636 bp PCR product was then digested overnight by restriction enzyme of 1 U PshA I (TaKaRa, Japan). The -692TT genotype produced a single 636 bp fragment, the -692CC genotype produced two fragments of 235 bp and 401 bp, and the heterozygous -692CT genotype produced three fragments of 636 bp, 235 bp and 401 bp. Genotyping was performed without knowing the case/control status of the subjects. Twelve DNA samples of EH cases were randomly selected to have sequencing analysis and the results were 100% concordant with the restriction fragment length polymorphism (RFLP) results.
Statistical Analysis
All continuous variables were expressed as mean ± standard deviation. Differences in selected demographic characteristics, selected variables and frequencies of the genotypes and alleles of CALCA between the cases and controls were evaluated using the chi-square test and/or Student's t test. The association of CALCA genotypes with EH risk were estimated by computing the odds ratios (ORs) and their 95% CIs from multiple Logistic regression analyses with adjustment for gender, age, smoking history, dyslipoproteinemia, family history of premature cardiovascular disease and obesity. The Hardy-Weinberg equilibrium was tested by a chi-square test to compare the observed genotype frequencies with the expected frequency among the control subjects. Stratification analysis was performed according to different groups of selected variants. All the statistical analyses were performed with Statistical Package for the Social Science (SPSS) 15.0. All the P values were two sided and with the significant levels of P <0.05.
Results
Human CGRP includes two subtypes, alpha-and beta-CGRP (CALCA and CALCB), and CALCB shows high sequence homology with CALCA. In the National The characteristics of the 293 EH cases and 208 controls included in the study were summarized in Table 3 . The mean age was 50 years (±12 years) for cases and 49 years (±11 years) for controls, which was adequately matched on age as suggested by the Student's t test (P=0.560). Compared with the control subjects, the EH cases had a significantly higher family history of EH (P <0.001), and had a significantly higher serum TBIL (P <0.001) and BS (P=0. 215). Moreover, as shown in Table 3, serum HDL was significantly lower in EH cases (P <0.001).
The observed genotypes for this polymorphism among the control subjects were both in Hardy-Weinberg equilibrium. The genotype distributions of CALCA T-692C in the cases and controls and their association with EH are shown in Table 4 . For the CALCA T-692C polymorphism the genotype frequencies of TT, TC and CC were 85.1%, 14.9% and 0 in the controls, respectively, which were significantly different from the EH cases (71.7% TT , 26.9% TC and 1.4% CC) (χ2=13.734,
P=0.001).
Logistic regression analyses revealed that compared with the TT genotype, the adjusted OR of EH for subjects carrying TC and combined genotypes TC +CC were 1.942 (95% CI: 1.216-3.103) and 2.093 (95% CI: 1.317-3.326), respectively. The frequencies of the C allele was 14.85% in EH group, and 7.45% in control group, the prevalence of C alleles in the EH subjects and controls were significantly incomparable (P <0.001). In addition, the risk of EH associated with premature cardiovascular disease (adjusted OR=9.114, 95% CI: 2.105-39.455, P=0.003).
Discussion
It is generally believed that the neuropeptide CGRP plays an integral role in the pathophysiology of hypertension. In experimental animal models, strong evidence supports the hypothesis that reduction both in alpha-and beta-CGRP could contribute to blood pressure elevation.10 Up to now, differences between normal and hypertensive patients in the concentration of plasma CGRP are uncertain. Previous studies have shown that plasma CGRP concentrations were significantly lower in hypertensive patients and preeclamptic pregnancies than in normotensive controls.11,12 The present study demonstrates that calcium intake and anti-hypertension drugs enhance the release or response of endogenous CGRP, resulting in a decrease in blood pressure. 13 In addition, intra-arterial CGRP infusions have been reported to induce vasodilation in a dose-dependent manner in the human forearm, increase forearm blood flow ratio and lower blood pressure.14,15 These results are consistent with the hypothesis that the decrease in CGRP synthesis and release contributes to elevated blood pressure. In contrast, other studies have shown increased plasma CGRP levels in patients with hypertension and shown a significant positive correlation between systolic and diastolic blood pressure. 16 The increase in CGRP levels, or the enhancement of vascular sensitivity response to CGRP, plays a beneficial compensatory depressor role in the development of hypertension. Some functional studies reported that CALCA gene knockout accelerated hypertension-induced heart and kidney damage. Therefore, we reasoned that polymorphisms of CALCA genes may contribute to EH susceptibility in the general population. However, there has been only one report dealing with the relationship between the CALCA gene variants and EH. In a study in Japanese a novel 2-bp microdeletion polymorphism was discovered in intron 1 of the CALCA and showed that the CALCA gene could be the susceptibility gene of EH.22 In our population-based case-control study of EH, we investigated, for the first time, the association of SNP (CALCA T-692C) with the risk of EH in a Han population in Hunan province of middle China. We found that CALCA T-692C was associated with EH risk, suggesting that this variant may play a role in the etiology of EH. However, these results are preliminary because of the limited sample size in the subgroup populations and need for validation in a further larger studies. Although the main findings of current study were positive and encouraging, several limitations of this study need to be addressed. First, we can not rule out the possibility that other, as yet unidentified, alterations in genes involved in cell cycle and DNA replication influence the risk of developing EH. In addition, because of the populationbased design of the study, these results may not be generalizable to the general population. Genetic polymorphisms often vary between ethnic groups. Furthermore, the sample size of the EH cases was not large enough to detect a small effect from very low penetrance genes or SNPs. In conclusion, our study provides evidence for association of the CALCA T-692C variant genotypes with risk of EH in this study population. A large prospective study is needed to verify our findings, particularly in subjects with a family history of EH.
